That might not be a bad move. The 10% move downward after the announced sale of common stock wasn't surprising. I'm still a hold. Long term the stock is good, but short term still think it could pull back more. If they start to acquire other BioTechs than I am a strong buyer. Can see them planing to be a household name. Dr. Crooke has always had a "world domination" type of mind set when it came to ISIS. Right now there are just to many unknowns.